Immunotherapy in locally advanced cervix cancer: A critical appraisal of the FDA indication based on ENGOT-CX11/GOG-3047/KEYNOTE-A18.

Authors :: Monk BJ
Tewari KS
Randall LM
Pothuri B
Slomovitz BM
Coleman RL
Herzog TJ
Source :: Gynecologic oncology [Gynecol Oncol] 2024 Sep; Vol. 188, pp. 81-82. Date of Electronic Publication: 2024 Jun 26.
Publication Year :: 2024

Subjects :: Humans
Female
United States
Immunotherapy methods
Immune Checkpoint Inhibitors therapeutic use
Drug Approval
Uterine Cervical Neoplasms therapy
Uterine Cervical Neoplasms pathology
Uterine Cervical Neoplasms immunology
United States Food and Drug Administration

Full Text Access

Tools